Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation

Inflammation Research

Volumn 59, Issue 6, 2010, Pages 463-469

  Henningsen, Kristoffer Mads ^a   Nilsson, Brian ^a   Johansen, Julia S ^a   Chen, Xu ^a   Pehrson, Steen ^a   Svendsen, Jesper Hastrup ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atrial fibrillation; HS CRP; Inflammation; Radiofrequency catheter ablation; YKL 40

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIARRHYTHMIC AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLASMA PROTEIN; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; LECTINS; LOGISTIC MODELS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 77953324157     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0146-z     Document Type: Article

References (45)

1. WM Feinberg JL Blackshear A Laupacis R Kronmal RG Hart 1995 Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 469 473 10.1001/archinte.155.5.469 1:STN:280:DyaK2M7mvV2nsg%3D%3D 7864703
2. J Friberg H Scharling N Gadsboll GB Jensen 2003 Sex-specific increase in the prevalence of atrial fibrillation (the Copenhagen City Heart Study) Am J Cardiol 92 1419 1423 10.1016/j.amjcard.2003.08.050 14675577 (Pubitemid 37532563)
3. A Frustaci C Chimenti F Bellocci E Morgante MA Russo A Maseri 1997 Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1180 1184 1:STN:280:DyaK2svjtFCnsA%3D%3D 9286947
4. MC Wijffels CJ Kirchhof R Dorland MA Allessie 1995 Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1954 1968 1:STN:280:DyaK2MvgtFemtg%3D%3D 7671380
5. MK Chung DO Martin D Sprecher O Wazni A Kanderian CA Carnes JA Bauer PJ Tchou MJ Niebauer A Natale DR Van Wagoner 2001 C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2886 2891 10.1161/hc4901.101760 1:CAS:528:DC%2BD38XjvVKisw%3D%3D 11739301
6. MD Engelmann JH Svendsen 2005 Inflammation in the genesis and perpetuation of atrial fibrillation Eur Heart J 26 2083 2092 10.1093/eurheartj/ehi350 1:CAS:528:DC%2BD2MXht1SgtbvN 15975993 (Pubitemid 41408600)
7. EM Kallergis EG Manios EM Kanoupakis HE Mavrakis SG Kolyvaki GM Lyrarakis GI Chlouverakis, et al. 2008 The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation Heart 94 200 204 10.1136/hrt.2006.108688 1:CAS:528:DC%2BD1cXit1KktLw%3D 17575330 (Pubitemid 351211730)
8. ML Loricchio C Cianfrocca V Pasceri L Bianconi A Auriti L Calo F Lamberti, et al. 2007 Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion Am J Cardiol 99 1421 1424 10.1016/j.amjcard.2006.12.074 1:CAS:528:DC%2BD2sXlt1equr8%3D 17493472 (Pubitemid 46691310)
9. E Watanabe T Arakawa T Uchiyama I Kodama H Hishida 2006 High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion Int J Cardiol 108 346 353 10.1016/j.ijcard.2005.05.021 15964643 (Pubitemid 43339801)
10. Henningsen KM, Nilsson B, Bruunsgaard H, Chen X, Pedersen BK, Svendsen JH. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Scand Cardiovasc J. 2008;43:285-91.
11. GH Renkema RG Boot FL Au WE Donker-Koopman A Strijland AO Muijsers M Hrebicek, et al. 1998 Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages Eur J Biochem 251 504 509 10.1046/j.1432-1327.1998.2510504.x 1:CAS:528:DyaK1cXnvFSisQ%3D%3D 9492324 (Pubitemid 28080953)
12. B Volck PA Price JS Johansen O Sorensen TL Benfield HJ Nielsen J Calafat, et al. 1998 YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils Proc Assoc Am Physicians 110 351 360 1:CAS:528:DyaK1cXltFWisrc%3D 9686683
13. KM Malinda L Ponce HK Kleinman LM Shackelton AJ Millis 1999 Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells Exp Cell Res 250 168 173 10.1006/excr.1999.4511 1:CAS:528:DyaK1MXktV2ktro%3D 10388530 (Pubitemid 29391580)
14. LM Shackelton DM Mann AJ Millis 1995 Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling J Biol Chem 270 13076 13083 10.1074/jbc.270.22.13076 1:CAS:528:DyaK2MXmtV2itLo%3D 7768902
15. RG Boot TA van Achterberg BE van Aken GH Renkema MJ Jacobs JM Aerts CJ de Vries 1999 Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages Arterioscler Thromb Vasc Biol 19 687 694 1:CAS:528: DyaK1MXitFGnsb0%3D 10073974
16. D Baeten AM Boots PG Steenbakkers D Elewaut E Bos GF Verheijden G Berheijden, et al. 2000 Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis Arthritis Rheum 43 1233 1243 10.1002/1529-0131(200006)43:6<1233::AID- ANR6>3.0.CO;2-9 1:STN:280:DC%2BD3czhtl2htw%3D%3D 10857782 (Pubitemid 30416308)
17. JS Johansen B Baslund C Garbarsch M Hansen M Stoltenberg I Lorenzen PA Price 1999 YKL-40 in giant cells and macrophages from patients with giant cell arteritis Arthritis Rheum 42 2624 2630 10.1002/1529-0131(199912)42:12<2624:: AID-ANR17>3.0.CO;2-K 1:CAS:528:DC%2BD3cXjslanug%3D%3D 10616010 (Pubitemid 30327181)
18. N Junker JS Johansen CB Andersen PE Kristjansen 2005 Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer Lung Cancer 48 223 231 10.1016/j.lungcan.2004.11.011 15829322
19. M Kucur FK Isman B Karadag VA Vural S Tavsanoglu 2007 Serum YKL-40 levels in patients with coronary artery disease Coron Artery Dis 18 391 396 10.1097/MCA.0b013e328241d991 17627189 (Pubitemid 47186840)
20. C Nojgaard NB Host IJ Christensen SH Poulsen K Egstrup PA Price JS Johansen 2008 Serum levels of YKL-40 increases in patients with acute myocardial infarction Coron Artery Dis 19 257 263 10.1097/MCA.0b013e3282f40dd5 18480670
21. Y Wang RS Ripa JS Johansen A Gabrielsen DA Steinbruchel T Friis L Bindslev, et al. 2008 YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease Scand Cardiovasc J 42 295 302 10.1080/14017430802220567 1:CAS:528:DC%2BD1cXhtFCitLzL 18615353
22. KM Henningsen ST Therkelsen JS Johansen H Bruunsgaard JH Svendsen 2009 YKL-40, a new biomarker for atrial fibrillation? Europace 11 1032 1036 10.1093/europace/eup103 19411674
23. J Kastrup JS Johansen P Winkel JF Hansen P Hildebrandt GB Jensen CM Jespersen, et al. 2009 High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease Eur Heart J 30 1066 1072 10.1093/eurheartj/ehp049 1:CAS:528: DC%2BD1MXlsVChu70%3D 19270316
24. B Nilsson X Chen S Pehrson L Kober J Hilden JH Svendsen 2006 Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: a randomized trial of the ostial versus the extraostial ablation strategy Am Heart J 152 537 538 10.1016/j.ahj.2006.05.029 16923426 (Pubitemid 44233434)
25. M Haissaguerre P Jais DC Shah S Garrigue A Takahashi T Lavergne M Hocini, et al. 2000 Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci Circulation 101 1409 1417 1:STN:280:DC%2BD3c3gt1WlsQ%3D%3D 10736285
26. C Pappone G Oreto S Rosanio G Vicedomini M Tocchi F Gugliotta A Salvati, et al. 2001 Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation Circulation 104 2539 2544 10.1161/hc4601.098517 1:STN:280:DC%2BD3MnmvVOltw%3D%3D 11714647
27. C Ober Z Tan Y Sun JD Possick L Pan R Nicolae S Radford, et al. 2008 Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function N Engl J Med 358 1682 1691 10.1056/NEJMoa0708801 1:CAS:528: DC%2BD1cXksl2hu7Y%3D 18403759 (Pubitemid 351549915)
28. JS Johansen 2006 Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer Dan Med Bull 53 172 209 1:CAS:528:DC%2BD28XnvFansb8%3D 17087877
29. Y Erzin H Uzun A Karatas AF Celik 2008 Serum YKL-40 as a marker of disease activity and structure formation in patients with Crohn's disease J Gastroenterol Hepatol 23 357 362 10.1111/j.1440-1746.2007.05121.x
30. I Vind JS Johansen PA Price P Munkholm 2003 Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease Scand J Gastroenterol 38 599 605 10.1080/00365520310000537 1:CAS:528: DC%2BD3sXlt1Crtbg%3D 12825867 (Pubitemid 36724038)
31. AR Nielsen C Erikstrup JS Johansen CP Fischer P Plomgaard R Krogh-Madsen S Taudorf, et al. 2008 Plasma YKL-40: a BMI-independent marker of type 2 diabetes Diabetes 57 3078 3082 10.2337/db08-0182 1:CAS:528:DC%2BD1MXhsleis70%3D 18650368
32. CN Rathcke F Persson L Tarnow P Rossing H Vestergaard 2009 YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria Diabetes Care 32 323 328 10.2337/dc08-1144 1:CAS:528:DC%2BD1MXis1WrsL4%3D 18957531
33. JS Johansen BV Jensen A Roslind D Nielsen PA Price 2006 Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev 15 194 202 10.1158/1055-9965.EPI-05-0011 1:CAS:528:DC%2BD28Xhs1Wrs7s%3D 16492905 (Pubitemid 43342164)
34. P Mehta R Ploutz-Snyder J Nandi SR Rawlins SO Sanderson RA Levine 2008 Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C Am J Gastroenterol 103 928 936 10.1111/j.1572-0241.2007.01761.x 18371145 (Pubitemid 351501097)
35. S Pungpapong DP Nunes M Krishna R Nakhleh K Chambers M Ghabril RC Dickson, et al. 2008 Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C Liver Transpl 14 1294 1302 10.1002/lt.21508 18756457
36. JS Johansen N Milman M Hansen C Garbarsch PA Price N Graudal 2005 Increased serum YKL-40 in patients with pulmonary sarcoidosis-a potential marker of disease activity? Respir Med 99 396 402 10.1016/j.rmed.2004.09.016 15763444 (Pubitemid 40347821)
37. CG Lee D Hartl GR Lee B Koller H Matsuura CA Da Silva MH Sohn, et al. 2009 Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis J Exp Med 206 1149 1166 10.1084/jem.20081271 1:CAS:528:DC%2BD1MXlvVGmu78%3D 19414556
38. H Ling AD Recklies 2004 The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha Biochem J 380 651 659 10.1042/BJ20040099 1:CAS:528:DC%2BD2cXltVahu7g%3D 15015934 (Pubitemid 38850506)
39. AD Recklies C White H Ling 2002 The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways Biochem J 365 119 126 10.1042/BJ20020075 1:CAS:528:DC%2BD38XlsV2htbs%3D 12071845 (Pubitemid 34756146)
40. AD Recklies H Ling C White SM Bernier 2005 Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes J Biol Chem 280 41213 41221 10.1074/jbc.M510146200 1:CAS:528:DC%2BD2MXhtlShsbzM 16234240 (Pubitemid 41832176)
41. GL Chupp CG Lee N Jarjour YM Shim CT Holm S He JD Dziura, et al. 2007 A chitinase-like protein in the lung and circulation of patients with severe asthma N Engl J Med 357 2016 2027 10.1056/NEJMoa073600 1:CAS:528: DC%2BD2sXhtlWis7rO 18003958 (Pubitemid 350106709)
42. JS Johansen PE Hoyer LA Larsen PA Price K Mollgard 2007 YKL-40 protein expression in the early developing human musculoskeletal system J Histochem Cytochem 55 1213 1228 10.1369/jhc.7A7245.2007 1:CAS:528:DC%2BD2sXhtl2ju7zI 17712177 (Pubitemid 350156079)
43. S Letuve A Kozhich N Arouche M Grandsaigne J Reed MC Dombret PA Kiener, et al. 2008 YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages J Immunol 181 5167 5173 1:CAS:528:DC%2BD1cXhtFaru7rF 18802121
44. A Saidi S Javerzat A Bellahcene J De Vos L Bello V Castronovo M Deprez, et al. 2008 Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma Int J Cancer 122 2187 2198 10.1002/ijc.23313 1:CAS:528:DC%2BD1cXkslyns7o%3D 18092325 (Pubitemid 351542321)
45. SK Therkelsen BA Groenning JH Svendsen GB Jensen 2006 Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion Am J Cardiol 97 8 1213 1219 10.1016/j.amjcard.2005.11.040 16616028